N Engl J Med 341:709717 Rossignol P, Dobre D, McMurray JJ et al (2014) Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
Glass and certain types of plastic are typically recommended
Looking at 7 trials, on average, the therapeutic dose of tirzepatide giving the Importantly, to have a chance of achieving these results, you must stick to a low-calorie diet and exercise regularly
Senthelal, S., Li, J., Ardeshirzadeh, S., & others
The cold sensations reported by patients are generally considered secondary to the weight loss process rather than a specific adverse reaction to the medication itself
The difference